The Role and Regulatory Mechanism of Transcription Factor EB in Health and Diseases

Shengyu Zhu, Ren-qi Yao, Yuxuan Li, Pengyue Zhao, Chao Ren, Xiaohui Du, Yong-ming YaoFrontiers in Cell and Developmental Biology 2021 · DOI

Abstract

Transcription factor EB (TFEB) is a member of the microphthalmia-associated transcription factor/transcription factor E (MiTF/TFE) family and critically involved in the maintenance of structural integrity and functional balance of multiple cells. In this review, we described the effects of post-transcriptional modifications, including phosphorylation, acetylation, SUMOylation, and ubiquitination, on the subcellular localization and activation of TFEB. The activated TFEB enters into the nucleus and induces the expressions of targeted genes. We then presented the role of TFEB in the biosynthesis of multiple organelles, completion of lysosome-autophagy pathway, metabolism regulation, immune, and inflammatory responses. This review compiles existing knowledge in the understanding of TFEB regulation and function, covering its essential role in response to cellular stress. We further elaborated the involvement of TFEB dysregulation in the pathophysiological process of various diseases, such as the catabolic hyperactivity in tumors, the accumulation of abnormal aggregates in neurodegenerative diseases, and the aberrant host responses in inflammatory diseases. In this review, multiple drugs have also been introduced, which enable regulating the translocation and activation of TFEB, showing beneficial effects in mitigating various disease models. Therefore, TFEB might serve as a potential therapeutic target for human diseases.

Introduction

Cells are constantly under pressure from nutrient scarcity, protein misfolding, and organelle damage. To survive, they rely on a sophisticated "waste management" system—the lysosome-autophagy pathway. Transcription Factor EB (TFEB) acts as the "master regulator" of this cellular recycling and metabolic adaptation. By controlling the Coordinated Lysosomal Expression and Regulation (CLEAR) gene network, TFEB dictates how cells respond to stress. However, its regulation is incredibly nuanced, involving a complex interplay of molecular signals that toggle it between the cytoplasm and nucleus.

Regulatory Mechanisms of TFEB

TFEB’s activity is primarily determined by its subcellular localization. In nutrient-rich conditions, TFEB is sequestered in the cytoplasm. This is largely mediated by the mechanistic target of rapamycin complex 1 (mTORC1), which phosphorylates TFEB at specific serine residues, notably S122, S142, and S211. Once phosphorylated, TFEB binds to 14-3-3 proteins, preventing its entry into the nucleus.

Conversely, under conditions of cellular stress or nutrient deprivation, TFEB is dephosphorylated. A key player in this process is Calcineurin, a phosphatase activated by the release of calcium from the lysosome via the MCOLN1 channel. Dephosphorylated TFEB dissociates from 14-3-3 proteins and translocates to the nucleus, where it binds to CLEAR elements in the promoters of target genes to initiate transcription.

Regulatory mechanisms of TFEB subcellular localization and activation, highlighting the roles of mTORC1 and Calcineurin.

Functional Diversity: Beyond the Lysosome

While TFEB is most famous for its role in lysosomal biogenesis and autophagy, its influence extends to a broad range of cellular processes. It is involved in the biogenesis of other organelles, including mitochondria (via the PGC-1α axis) and peroxisomes. Furthermore, TFEB plays a critical role in immune and inflammatory responses, regulating macrophage activation, bactericidal functions, and cytokine production.

The diverse physiological roles of TFEB across different cellular pathways, including autophagy, organelle biogenesis, and immune cell function.

Clinical Implications and Therapeutic Potential

The dysregulation of TFEB is linked to various human diseases, often presenting a "double-edged sword" scenario in oncology. In certain cancers, such as pancreatic and lung cancer, TFEB helps tumors survive metabolic stress by boosting autophagy. In TFEB-related Renal Cell Carcinoma (RCC), chromosomal translocations lead to massive TFEB overexpression, driving tumor growth. Conversely, in melanoma, over-activating TFEB can trigger autophagic cell death.

In neurodegenerative diseases like Alzheimer’s and Parkinson’s, TFEB is often "trapped" in the cytoplasm, leading to the accumulation of toxic protein aggregates. Restoring TFEB’s nuclear translocation has shown promise in clearing amyloid-beta, tau, and alpha-synuclein in animal models. Pharmacological modulation is an active area of research; for instance, the curcumin derivative C1 specifically binds the N-terminal of TFEB to enhance its nuclear translocation, showing significant reduction in amyloid plaques in Alzheimer’s models.

Conclusion and Future Directions

TFEB stands as a central hub for cellular homeostasis. While much is known about its role in the lysosome-autophagy axis, several gaps remain. The precise mechanisms of nuclear export—how TFEB returns to the cytoplasm—are still being elucidated. Furthermore, translating these findings into clinical therapies remains challenging due to the systemic nature of TFEB activity. Future research must explore TFEB’s role in non-lysosomal processes and track its activity across different stages of disease progression to develop more targeted, side-effect-free treatments.

Summary updated

Abstract

Transcription factor EB (TFEB) is a member of the microphthalmia-associated transcription factor/transcription factor E (MiTF/TFE) family and critically involved in the maintenance of structural integrity and functional balance of multiple cells. In this review, we described the effects of post-transcriptional modifications, including phosphorylation, acetylation, SUMOylation, and ubiquitination, on the subcellular localization and activation of TFEB. The activated TFEB enters into the nucleus and induces the expressions of targeted genes. We then presented the role of TFEB in the biosynthesis of multiple organelles, completion of lysosome-autophagy pathway, metabolism regulation, immune, and inflammatory responses. This review compiles existing knowledge in the understanding of TFEB regulation and function, covering its essential role in response to cellular stress. We further elaborated the involvement of TFEB dysregulation in the pathophysiological process of various diseases, such as the catabolic hyperactivity in tumors, the accumulation of abnormal aggregates in neurodegenerative diseases, and the aberrant host responses in inflammatory diseases. In this review, multiple drugs have also been introduced, which enable regulating the translocation and activation of TFEB, showing beneficial effects in mitigating various disease models. Therefore, TFEB might serve as a potential therapeutic target for human diseases. The limitation of this review is that the mechanism of TFEB-related human diseases mainly focuses on its association with lysosome and autophagy, which needs deep description of other mechanism in diseases progression after getting more advanced information.
BibTeX
@inproceedings{zhu2021role,
  author = {Shengyu Zhu and Ren-qi Yao and Yuxuan Li and Pengyue Zhao and Chao Ren and Xiaohui Du and Yong-ming Yao},
  title = {{The Role and Regulatory Mechanism of Transcription Factor EB in Health and Diseases}},
  booktitle = {Frontiers in Cell and Developmental Biology},
  year = {2021},
  doi = {10.3389/fcell.2021.667750},
}
Figure